3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Tuberous Sclerosis
1
Interventions
Sirolimus
7
Everolimus
5
ganaxolone
1
dactolisib
1
Vigabatrin
1
Sertraline
1
Selective Serotonin Reuptake Inhibitors
1
Propranolol
1
Aspirin
1
Anticonvulsants
1
2-chloro-4-(1-(4-fluorophenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl)pyridine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Tuberous Sclerosis
×
ganaxolone
×
Clear all
NCT04285346
2023-04-04
TSC
Marinus Pharmaceuticals
Phase 2
Completed
23 enrolled
9 charts